Predicted to enable several functions, including SAM domain binding activity; identical protein binding activity; and nucleosome binding activity. Predicted to be involved in several processes, including negative regulation of macromolecule biosynthetic process; regulation of megakaryocyte differentiation; and regulation of mitotic nuclear division. Predicted to be located in chromatin; condensed chromosome; and nucleoplasm. Predicted to be part of chromatin lock complex. Predicted to be active in nucleus. Orthologous to human L3MBTL1 (L3MBTL histone methyl-lysine binding protein 1).
RGD Description
Predicted to enable several functions, including SAM domain binding activity; identical protein binding activity; and nucleosome binding activity. Predicted to be involved in several processes, including negative regulation of macromolecule biosynthetic process; regulation of megakaryocyte differentiation; and regulation of mitotic nuclear division. Predicted to be located in chromatin; condensed chromosome; and nucleoplasm. Predicted to be part of chromatin lock complex. Predicted to be active in nucleus. Orthologous to human L3MBTL1 (L3MBTL histone methyl-lysine binding protein 1); PARTICIPATES IN ataxia telangiectasia-mutated (ATM) signaling pathway; histone modification pathway; INTERACTS WITH atrazine; bisphenol A; lead diacetate.